arrow
E

Erin C. Phipps

United States Public Health Service
H指数:27
被引数:6,523

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An Observational Study to Determine the Prevalence of COVID-19 Among Hospitalized Patients With Multidrug-Resistant Enterobacterales Infections and Clinical Outcomes, 10 US Sites, 2020-2022
2024-12-260
OA
Carbapenem-resistant Acinetobacter baumannii complex in the United States-An epidemiological and molecular description of isolates collected through the Emerging Infections Program, 2019

美国耐碳青霉烯类鲍曼不动杆菌复合体-通过新兴感染计划收集的分离株的流行病学和分子描述,2019

2024-09-017
OAAI
Carbapenem-Resistant and Extended-Spectrum β-Lactamase- Producing Enterobacterales in Children, United States, 2016-2020
2024-06-010
OAAI
Characteristics of Patients With Initial Clostridioides difficile Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences
2024-03-062
OA
Effectiveness of a Messenger RNA Vaccine Booster Dose Against Coronavirus Disease 2019 Among US Healthcare Personnel, October 2021-July 2022
2023-09-086
OA
Carbapenem-Resistant enterobacterales in individuals with and without health care risk factors -Emerging infections program, United States, 2012-2015
2023-01-0116
OAAI
Whole-Genome Sequencing Reveals Diversity of Carbapenem-Resistant Pseudomonas aeruginosa Collected through CDC's Emerging Infections Program, United States, 2016-2018
2022-09-2017
OA
Low Sensitivity of International Classification of Diseases, Tenth Revision Coding for Culture-Confirmed Candidemia Cases in an Active Surveillance System: United States, 2019-2020
2022-09-072
OA
Comparison of the Risk of Recurrent Clostridioides Difficile Infections Among Patients in 2018 Versus 2013
2022-08-176
OA
Epidemiology of extended-spectrum β-lactamase-producing Enterobacterales in five US sites participating in the Emerging Infections Program, 2017
2022-02-1415
OA
Risk Factors for SARS-CoV-2 Infection Among US Healthcare Personnel, May-December 2020
2022-01-0113
OAAI
The Landscape of Candidemia During the Coronavirus Disease 2019 (COVID-19) Pandemic
2021-06-18101
OA
Treatment Practices for Adults With Candidemia at 9 Active Surveillance Sites-United States, 2017-2018
2021-06-0314
OA
Colistin Heteroresistance Is Largely Undetected among Carbapenem-Resistant Enterobacterales in the United States
MBIO
IF4.7
2021-02-2343
OAAI
Association between Socioeconomic Status and Incidence of Community-Associated Clostridioides difficile Infection - United States, 2014-2015
2021-01-199
OA
Evaluation of Discrepancies in Carbapenem Minimum Inhibitory Concentrations Obtained at Clinical Laboratories Compared to a Public Health Laboratory
2020-11-021
OA
Whole-Genome Sequencing Reveals Diversity of Carbapenem-Resistant Pseudomonas aeruginosa Collected Through the Emerging Infections Program
2020-11-020
OAAI
Burden of Candidemia in the United States, 2017
2020-02-28110
OAAI